IRIS - Res&Arch Institutional Research Information System - Research & Archive

MARTELLI, Maria Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.255
AS - Asia 4.871
EU - Europa 4.793
SA - Sud America 829
AF - Africa 134
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 11
Totale 16.906
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.095
SG - Singapore 2.238
IT - Italia 1.150
IE - Irlanda 712
CN - Cina 646
BR - Brasile 632
RU - Federazione Russa 604
HK - Hong Kong 600
VN - Vietnam 527
SE - Svezia 490
UA - Ucraina 483
DE - Germania 335
FI - Finlandia 274
FR - Francia 251
KR - Corea 201
GB - Regno Unito 153
IN - India 103
BD - Bangladesh 100
TR - Turchia 88
CA - Canada 80
AR - Argentina 79
IQ - Iraq 57
AT - Austria 51
NL - Olanda 47
MX - Messico 43
ZA - Sudafrica 43
ID - Indonesia 36
CO - Colombia 35
PL - Polonia 33
UZ - Uzbekistan 33
BE - Belgio 32
LU - Lussemburgo 31
CZ - Repubblica Ceca 29
PH - Filippine 29
CH - Svizzera 27
ES - Italia 26
JP - Giappone 25
PK - Pakistan 25
SA - Arabia Saudita 24
MA - Marocco 22
EC - Ecuador 21
VE - Venezuela 16
LB - Libano 15
RO - Romania 14
LT - Lituania 13
AZ - Azerbaigian 12
CL - Cile 12
PY - Paraguay 12
AE - Emirati Arabi Uniti 11
ET - Etiopia 11
IL - Israele 10
JO - Giordania 10
KE - Kenya 10
MY - Malesia 10
TH - Thailandia 10
BO - Bolivia 9
GR - Grecia 9
TN - Tunisia 9
AU - Australia 8
EG - Egitto 8
EU - Europa 8
KZ - Kazakistan 8
NP - Nepal 8
OM - Oman 8
PE - Perù 7
KG - Kirghizistan 6
PA - Panama 6
AL - Albania 5
CR - Costa Rica 5
DZ - Algeria 5
JM - Giamaica 5
PT - Portogallo 5
QA - Qatar 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
GE - Georgia 4
NI - Nicaragua 4
SV - El Salvador 4
AO - Angola 3
BH - Bahrain 3
CI - Costa d'Avorio 3
KW - Kuwait 3
LK - Sri Lanka 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
UG - Uganda 3
BG - Bulgaria 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
EE - Estonia 2
GD - Grenada 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
MU - Mauritius 2
Totale 16.874
Salva come PNG Salva come JPEG
Città #
Singapore 1.586
Chandler 768
Dublin 712
San Jose 686
Hong Kong 600
Perugia 498
Ashburn 455
San Mateo 369
Boardman 288
Santa Clara 250
Jacksonville 225
Dong Ket 216
Moscow 212
Seoul 200
Lauterbourg 173
Beijing 162
Altamura 161
Medford 157
Princeton 153
Wilmington 125
Lawrence 118
Munich 117
Andover 113
Los Angeles 112
Ann Arbor 109
Ho Chi Minh City 108
New York 106
Helsinki 92
The Dalles 69
Des Moines 67
Piscataway 65
Turku 59
Hanoi 57
São Paulo 56
Council Bluffs 47
Orem 43
Izmir 42
Saint Petersburg 41
Dallas 39
Rome 38
Frankfurt am Main 36
Brussels 32
Falls Church 32
Belo Horizonte 30
Dudelange 30
Milan 30
Brooklyn 29
Johannesburg 28
Norwalk 28
Redmond 28
San Francisco 28
Pisa 26
Rio de Janeiro 26
Baghdad 25
Nuremberg 25
San Paolo di Civitate 25
Denver 24
London 24
Montreal 24
Woodbridge 24
Tokyo 23
Amsterdam 22
Chennai 22
Chicago 22
Houston 22
Shanghai 20
Tashkent 20
Vienna 20
Dhaka 19
Phoenix 19
Warsaw 19
Haiphong 18
Mexico City 18
Redwood City 18
Toronto 18
Boston 17
Atlanta 16
Stockholm 16
Bologna 15
Florence 15
Poplar 15
Foligno 14
Jakarta 14
Manchester 14
Charlotte 13
Falkenstein 13
Manila 13
Auburn Hills 12
Columbus 12
Hefei 12
New Delhi 12
Ankara 11
Barnet 11
Bucharest 11
Buffalo 11
Da Nang 11
Mumbai 11
Baku 10
Brno 10
Buenos Aires 10
Totale 10.667
Salva come PNG Salva come JPEG
Nome #
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 211
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 178
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 176
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 173
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? 163
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 157
Eicosapentaenoic acid demethylates a single CpG that mediates expression of tumor suppressor CCAAT/enhancer-binding protein delta in U937 leukemia cells. 150
Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy. 148
Maesopsin 4-O-D-glucoside, a natural compound isolated from the leaves of Artocarpus tonkinensis, inhibits proliferation and up-regulates HMOX1, SRXN! and BCAS3 in acute myeloid leukemia 146
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 143
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 143
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. 142
ARPIR: automatic RNA-Seq pipelines with interactive report 139
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 136
Mutant NPM1 Maintains the Leukemic State through HOX Expression 135
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features 132
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 132
Germline NPM1 mutations lead to altered rRNA 2′-O-methylation and cause dyskeratosis congenita 131
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 131
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives. 128
A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF. 127
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 126
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 123
Glucocorticoid-induced activation of caspase-8 protects the glucocorticoid-induced protein Gilz from proteasomal degradation and induces its binding to Sumo-1 in murine thymocytes 120
Dactinomycin in NPM1-Mutated Acute Myeloid Leukemia 120
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 119
Acute Myeloid Leukemia with mutated nucleophosmin (NPM1). Any hope for a targeted therapy? 118
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 117
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 117
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML 116
Genotype-phenotype correlations in patients with de novo KCNQ2 pathogenic variants 116
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 115
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 114
EML4-ALK rearrangement in non-small-cell lung cancer and non-tumor lung tissues. 113
Absence of BRAF-V600E in the human cell lines BONNA-12, ESKOL, HAIR-M, and HC-1 questions their origin from hairy cell leukemia. 113
The EML4-ALK transcript but not the fusion protein can be expressed in reactive and neoplastic lymphoid tissues. 112
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo [4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia 112
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia. 111
Pharmacological modulation of caspase-8 in thymus-related medical conditions. 111
Constant Activation of the RAF-MEK-ERK Pathway As a Diagnostic and Therapeutic Target in Hairy Cell Leukemia. 110
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 110
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients 110
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 109
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 108
BRAF mutations in hairy-cell leukemia. 108
CD123 (IL-3R alpha) IS CONSISTENTLY EXPRESSED ON ACUTE MYELOID LEUKEMIA (AML) CARRYING NUCLEOPHOSMIN (NPM1) GENE MUTATION 108
THE BRAF-MEK-ERK PATHWAY IN HAIRY CELL LEUKEMIA: A COMPREHENSIVE DISSECTION IN PRIMARY LEUKEMIC CELLS OF ITS BIOLOGICAL AND THERAPEUTIC RELEVANCE 108
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin 108
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity 108
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 108
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 107
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 106
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 106
Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI. 106
WESTERN BLOT IDENTIFICATION OF NPM1 LEUKEMIC MUTANTS IN CYTOLOGICAL AML SAMPLES: A POWERFUL DIAGNOSTIC TECHNIQUE 105
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. 105
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 104
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia 104
Molecular and cytogenetic remission in a case of subtype M4E acute myelogenous leukemia with minimal monochemotherapy: high sensitivity or spontaneous remission? 102
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 102
Biological and therapeutic relevance of the BRAF-MEK-ERK pathway in hairy cell leukemia 102
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. 101
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 101
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 101
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. 99
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 99
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 98
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 98
Cellular and Molecular Biology of Lymphoid Cell 98
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice 98
Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML. 98
Current status and future perspectives in targeted therapy of NPM1-mutated AML 97
Failure of gelsolin overexpression to regulate lymphocyte apoptosis. 97
CYTOPLASMIC MUTATED NUCLEOPHOSMIN DEFINES THE MOLECULAR STATUS OF A SIGNIFICANT FRACTION OF MYELOID SARCOMAS 97
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 97
Poor risk acute myelogenous leukemia patients undergoing the Fludarabine-Cytosine Arabinoside-Filgrastim regimen: multidrug resistance expression, granulocyte colony-stimulating factor priming activity and clinical response. 96
Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia. 96
Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients 96
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin 96
The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor 95
Stem cell mobilization in normal donors. 95
Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. 95
Flower cells of tropical descent: a challenging case of adult T-cell leukemia/lymphoma 94
MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis. 93
Whole-Exome Sequencing Identifies Recurrent Mutations of BCOR in Acute Myeloid Leukemia with Normal Karyotype 93
A curious novel combination of nucleophosmin (Npm1) gene mutations leading to aberrant cytoplasmic dislocation of npm1 in acute myeloid leukemia (aml) 93
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 92
Fibrin-associated large B-cell lymphoma: first case report within a cerebral artery aneurysm and literature review 92
BRAF V600E mutation in hairy cell leukemia: From bench to bedside 92
CD123 Is Consistently Expressed on NPM1-Mutated AML Cells 91
Absence of nucleophosmin leukemic mutants in B and T cells from AML with NPM1 mutations: Implications for the cell of origin of NPMC plus AML 91
Mutational landscape of AML with normal cytogenetics: biological and clinical implications 91
Actinomycin d targets npm1c-primed mitochondria to restore pml-driven senescence in aml therapy 91
Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family. 90
ADDITION OF THIOTEPA IMPROVES RESULTS IN T-CELL DEPLETED BONE-MARROW TRANSPLANT FOR ADVANCED LEUKEMIA 90
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 90
Role of caspase-8 in thymus function 89
Transformation by retroviral vectors of bone marrow-derived mesenchymal cells induces mitochondria-dependent cAMP-sensitive reactive oxygen species production. 87
Overlapping features of therapy-related and de novoNPM1-mutated AML 86
NPM1-mutated AML: targeting by disassembling 86
Totale 11.237
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.943
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.570 41 299 23 80 64 23 17 394 30 130 239 230
2022/20232.503 167 459 24 200 203 289 5 111 916 35 69 25
2023/20241.063 54 112 66 21 10 7 249 12 83 49 196 204
2024/20253.014 109 251 164 136 371 131 170 244 541 163 482 252
2025/20266.553 445 393 287 771 891 620 1.014 401 791 673 177 90
2026/202797 97 0 0 0 0 0 0 0 0 0 0 0
Totale 17.497